NYSEAM:STXSMedical Equipment
Stereotaxis (STXS) Could Be 53% Undervalued As Shelf Filings Raise Dilution Questions
Stereotaxis (STXS) recently filed two shelf registrations that together cover up to about $205.3 million of common equity, highlighting potential future capital raises that could affect dilution and investor sentiment toward the stock.
See our latest analysis for Stereotaxis.
The recent shelf registrations arrive during a weaker patch for Stereotaxis, with the stock closing at US$1.65 and recording a 30 day share price return down 9.34%, alongside a 1 year total shareholder return down 30.67%...